Log in to save to my catalogue

The citrullinated/native index of autoantibodies against hnRNP-DL predicts an individual “window of...

The citrullinated/native index of autoantibodies against hnRNP-DL predicts an individual “window of...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6e28ab54dbcf4c858aedc3ba90e27fcf

The citrullinated/native index of autoantibodies against hnRNP-DL predicts an individual “window of treatment success” in RA patients

About this item

Full title

The citrullinated/native index of autoantibodies against hnRNP-DL predicts an individual “window of treatment success” in RA patients

Publisher

London: BioMed Central Ltd

Journal title

Arthritis research & therapy, 2021-09, Vol.23 (1), p.1-16, Article 239

Language

English

Formats

Publication information

Publisher

London: BioMed Central Ltd

More information

Scope and Contents

Contents

Background There is a need for biomarker to identify patients "at risk" for rheumatoid arthritis (risk-RA) and to better predict the therapeutic response and in this study we tested the hypothesis that novel native and citrullinated heterogeneous nuclear ribonucleoprotein (hnRNP)-DL autoantibodies could be possible biomarkers. Methods Using protein...

Alternative Titles

Full title

The citrullinated/native index of autoantibodies against hnRNP-DL predicts an individual “window of treatment success” in RA patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_6e28ab54dbcf4c858aedc3ba90e27fcf

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6e28ab54dbcf4c858aedc3ba90e27fcf

Other Identifiers

ISSN

1478-6362,1478-6354

E-ISSN

1478-6362

DOI

10.1186/s13075-021-02603-x

How to access this item